Nova Leap Health Stock Market Value
NVLPF Stock | USD 0.18 0.02 10.00% |
Symbol | Nova |
Nova Leap 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nova Leap's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nova Leap.
06/05/2024 |
| 12/02/2024 |
If you would invest 0.00 in Nova Leap on June 5, 2024 and sell it all today you would earn a total of 0.00 from holding Nova Leap Health or generate 0.0% return on investment in Nova Leap over 180 days. Nova Leap is related to or competes with Ramsay Health, Fresenius, Ensign, Select Medical, Encompass Health, InnovAge Holding, and Enhabit. Nova Leap Health Corp. provides home and home health care services in the United States and Canada More
Nova Leap Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nova Leap's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nova Leap Health upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 14.26 | |||
Information Ratio | 0.0313 | |||
Maximum Drawdown | 47.34 | |||
Value At Risk | (14.29) | |||
Potential Upside | 11.76 |
Nova Leap Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Leap's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nova Leap's standard deviation. In reality, there are many statistical measures that can use Nova Leap historical prices to predict the future Nova Leap's volatility.Risk Adjusted Performance | 0.0468 | |||
Jensen Alpha | 0.461 | |||
Total Risk Alpha | (0.90) | |||
Sortino Ratio | 0.0167 | |||
Treynor Ratio | (0.49) |
Nova Leap Health Backtested Returns
Nova Leap appears to be out of control, given 3 months investment horizon. Nova Leap Health has Sharpe Ratio of 0.049, which conveys that the firm had a 0.049% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Nova Leap, which you can use to evaluate the volatility of the firm. Please exercise Nova Leap's Downside Deviation of 14.26, mean deviation of 4.33, and Risk Adjusted Performance of 0.0468 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Nova Leap holds a performance score of 3. The company secures a Beta (Market Risk) of -0.75, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Nova Leap are expected to decrease at a much lower rate. During the bear market, Nova Leap is likely to outperform the market. Please check Nova Leap's potential upside, as well as the relationship between the skewness and day median price , to make a quick decision on whether Nova Leap's current price movements will revert.
Auto-correlation | -0.08 |
Very weak reverse predictability
Nova Leap Health has very weak reverse predictability. Overlapping area represents the amount of predictability between Nova Leap time series from 5th of June 2024 to 3rd of September 2024 and 3rd of September 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nova Leap Health price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Nova Leap price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.08 | |
Spearman Rank Test | -0.5 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Nova Leap Health lagged returns against current returns
Autocorrelation, which is Nova Leap otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nova Leap's otc stock expected returns. We can calculate the autocorrelation of Nova Leap returns to help us make a trade decision. For example, suppose you find that Nova Leap has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Nova Leap regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nova Leap otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nova Leap otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nova Leap otc stock over time.
Current vs Lagged Prices |
Timeline |
Nova Leap Lagged Returns
When evaluating Nova Leap's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nova Leap otc stock have on its future price. Nova Leap autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nova Leap autocorrelation shows the relationship between Nova Leap otc stock current value and its past values and can show if there is a momentum factor associated with investing in Nova Leap Health.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Nova OTC Stock
Nova Leap financial ratios help investors to determine whether Nova OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Leap security.